A commentary on 'Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study'

Int J Surg. 2024 Apr 1;110(4):2442-2443. doi: 10.1097/JS9.0000000000001052.
No abstract available

Publication types

  • Multicenter Study

MeSH terms

  • Carcinoma, Hepatocellular* / mortality
  • Carcinoma, Hepatocellular* / pathology
  • Carcinoma, Hepatocellular* / surgery
  • Carcinoma, Hepatocellular* / therapy
  • Chemoembolization, Therapeutic* / methods
  • Cohort Studies
  • Hepatectomy*
  • Humans
  • Liver Neoplasms* / mortality
  • Liver Neoplasms* / pathology
  • Liver Neoplasms* / surgery
  • Liver Neoplasms* / therapy
  • Retrospective Studies
  • Treatment Outcome